Cited by 226Pancreatic function and diabetesDiabetes and associated disordersDiabetes Management and Research

Update on Islet Transplantation

Open access
McCall, M., James Shapiro, A. M.·2012·Cold Spring Harbor Perspectives in Medicine

Abstract

Clinical islet transplantation has progressed considerably over the past 12 years, and >750 patients with type 1 diabetes have received islet transplants internationally over this time. Many countries are beginning to accept the transition from research to accepted and funded clinical care, especially for patients with brittle control that cannot be stabilized by more conventional means. Major challenges remain, including the need for more than one donor, and the requirement for potent, chronic immunosuppression. Combining immunological tolerance both to allo- and autoantigens, and a limitless expandable source of stem cell- or xenograft-derived insulin-secreting cells represent remaining hurdles in moving this effective treatment to a potential cure for all those with type 1 or 2 diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/cshperspect.a007823

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Primary islets often demonstrated progressive functional decline in the years following transplantation, necessitating patients to resume exogenous insulin injections over time.

    “Furthermore, primary islets often demonstrated progressive functional decline in the years following transplantation, necessitating patients to resume exogenous insulin injections overtime.”
  • Because of major cell loss during the immediate aftermath of transplantation, a high islet mass from multiple organ donors and several infusions was used in the clinic.

    “Because of this major cell loss during the immediate aftermath of transplantation, a high islet mass from multiple organ donors and several infusions was used in the clinic.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 100 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
McCall, M., & James Shapiro, A. M.
Affiliations
University of Alberta (CA)
Venue
Cold Spring Harbor Perspectives in Medicine
Published
2012-05-08
Volume
2
Issue
7
Pages
a007823-a007823
ISSN
2157-1422 (ISSN-L)
OpenAlex
W2111365775
Cited by
226
References
100
Citations by year
2026: 1 · 2025: 9 · 2024: 9 · 2023: 10 · 2022: 12 · 2021: 20 · 2020: 14 · 2019: 26 · 2018: 19 · 2017: 18 · 2016: 16 · 2015: 22 · 2014: 28 · 2013: 18 · 2012: 4
Type
posted content
Language
en
Open access
Locations
  • Cold Spring Harbor Perspectives in Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Diabetes Research Institute Foundation
  • Alberta Innovates - Health Solutions
  • Alberta Innovates
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Center for Research Resources
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
islet transplantation, type 1 diabetes, type 2 diabetes, immune tolerance, immunosuppression, insulin-secreting cells, stem cell-derived islets, clinical translation
MeSH terms
Animals, Diabetes Mellitus, Type 1, Humans, Immunosuppression Therapy, Inflammation, Necrosis, Tissue and Organ Procurement, Portal System, Tumor Necrosis Factor-alpha, Autoimmunity, Islets of Langerhans Transplantation, Apoptosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review